Oslo, Norway, 23rd from August 2024 Vistin Pharma ASA (VISTN) today announces financial results for the second quarter of 2024. Sales for the second quarter were NOK 106 million compared to NOK 107 million in the second quarter of 2023. Sales volume for the quarter increased by 4% compared to the second quarter of 2023; […]